1Bz-LSD, also known as 1-benzoyl-LSD or as SYN-L-018, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is thought to be a prodrug of LSD. The drug was patented by Lizard Labs in 2024. Subsequently, it was encountered online as a novel designer drug in July 2024. 1Bz-LSD has been sold in the form of blotter tabs and microdots, for instance containing 10μg and 200μg doses per unit. A deethylated metabolite, 1Bz-LAE, has been identified. 1Bz-LSD was first described in the scientific literature by 2026. It is not an explicitly controlled substance in the United States or in Canada.
See also Substituted lysergamide 1SB-LSD 1-Benzoyl-DMT
References
External links New lysergamide 1bz-LSD - r/researchchemicals - Reddit